The ASX biotech sector ran strongly in October, but the big-cap thoroughbreds found the track conditions more challenging.

Small caps continued to shine in October, with the ASX Small Ordinaries rising 2%, achieving a 25% YTD gain and significantly ...

Lithium may have turned a corner in October, while gold and copper both touched record highs before late pullbacks.

Optiscan has pioneered the world’s first miniaturised confocal microscope that allows doctors, pathologists and veterinarians ...

TG Metals has started drilling to extend down-dip resources at its Van Uden project in WA’s highly prospective Forrestania ...

ASX-listed tech companies have released their latest quarterly results, showing solid progress across key areas.

REA Group’s Eleanor Creagh reckons Bullock will hold fire at 3.6% today, calling last week’s CPI strong print a “watchful ...

If you're thinking of hiring a car while on holiday in Japan, here's eight things you need to know before you pick up the ...

With most of its sales now coming from the US, glaucoma device maker Nova Eye Medical is steering a course through global trade turbulence.

Armed with the latest tech and a human coach, The Australian's tech editor learned what makes the difference in the pursuit ...

Gallium fever lifts Mount Ridley to three-year highs as Western Yilgarn expands its footprint and Locksley lands a US$191m ...

Rising inflation has ruined chances of an early Christmas gift for people with home loans. See the 12 biggest cost culprits.